FAMI
BSX icon

Fideuram Asset Management (Ireland)’s Boston Scientific BSX Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Buy
15,595
+13,707
+726% +$744K 0.01% 627
2026
Q1 		$140K Sell
1,888
-28,420
-94% -$2.27M 0.02% 355
2025
Q4 		$3.12M Buy
+30,308
New +$2.97M 0.25% 103

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s BSX Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) increased its Boston Scientific (BSX) stake by 726% in Q2 2026, buying an estimated $744K and bringing the position to 15,595 shares worth $771K. The position accounts for 0.01% of the portfolio, ranked #627.

Fideuram Asset Management (Ireland) first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.12M in Q4 2025. 1,471 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 15,595 shares of Boston Scientific worth $771K as of Q2 2026.
  • Fideuram Asset Management (Ireland) bought 13,707 Boston Scientific shares in Q2 2026, an estimated $744K.
  • Boston Scientific made up 0.01% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #627 holding.
  • Fideuram Asset Management (Ireland) first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Fideuram Asset Management (Ireland)'s Boston Scientific position peaked at $3.12M in Q4 2025.
  • 1,471 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.